Real-world outcomes of siponimod in multiple sclerosis patients

被引:0
|
作者
Tan, Hongmei [1 ]
Quan, Chao [1 ]
机构
[1] Fudan Univ, Shanghai Med Coll, Huashan Hosp, Neurol, Shanghai, Peoples R China
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P1684/3109
引用
收藏
页码:1129 / 1129
页数:1
相关论文
共 50 条
  • [1] Real-world experience of secondary progressive multiple sclerosis patients treated with siponimod
    Totaro, Rocco
    Borriello, Giovanna
    Marinelli, Fabiana
    Bianco, Assunta
    Evangelista, Luana
    Mirabella, Massimiliano
    Cicia, Alessandra
    Marini, Carmine
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 1240 - 1241
  • [2] Real-world evidence on siponimod treatment in patients with secondary progressive multiple sclerosis
    Regner-Nelke, Liesa
    Pawlitzki, Marc
    Willison, Alice
    Rolfes, Leoni
    Oezalp, Sinem-Hilal
    Nelke, Christopher
    Koelsche, Tristan
    Korsen, Melanie
    Grothe, Matthias
    Groppa, Sergiu
    Luessi, Felix
    Engel, Sinah
    Nelles, Gereon
    Bonmann, Eckhard
    Roick, Holger
    Friedrich, Anke
    Knorn, Philipp
    Landefeld, Harald
    Biro, Zoltan
    Ernst, Michael
    Bayas, Antonios
    Menacher, Martina
    Akgun, Katja
    Kleinschnitz, Christoph
    Ruck, Tobias
    Ziemssen, Tjalf
    Pul, Refik
    Meuth, Sven G.
    NEUROLOGICAL RESEARCH AND PRACTICE, 2022, 4 (01):
  • [3] Siponimod-induced lymphopenia in patients with secondary progressive multiple sclerosis: a real-world experience
    Capuano, Rocco
    De Marca, Umberto
    Di Filippo, Federico
    Scannapieco, Sara
    Andreozzi, Valentina
    Giordano, Caterina
    Bisecco, Alvino
    D'Ambrosio, Alessandro
    Risi, Mario
    Gallo, Antonio
    Conti, Valeria
    Filippelli, Amelia
    Barone, Paolo
    Di Gregorio, Maria
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 1097 - 1098
  • [4] Real World Experience with Siponimod in Secondary Progressive Multiple Sclerosis Patients
    Gomez-Estevez, I.
    Garcia Vasco, L.
    Alba Suarez, E.
    Quezada Sanchez, J.
    Oreja-Guevara, C.
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 97 - 97
  • [5] A real-world, retrospective study to assess the effectiveness and safety of siponimod in Chinese patients with relapsing forms of multiple sclerosis
    Zhang, Yao
    Liu, Hongbo
    Zhou, Ming
    Li, Zheng
    Li, Bingbing
    Cai, Min
    Shi, Xiaofang
    Liu, Lyra
    Lin, Anne
    Xu, Yan
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 1100 - 1100
  • [6] Real-world treatment outcomes and safety of natalizumab in Finnish multiple sclerosis patients
    Verkkoniemi-Ahola, Auli
    Hartikainen, Paivi
    Hassi, Katja
    Kuusisto, Hanna
    Lahdenpera, Sanni
    Mehtala, Juha
    Viitala, Matias
    Ylisaukko-oja, Tero
    Soilu-Hanninen, Merja
    MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL, 2023, 9 (04)
  • [7] Impact of Siponimod on Clinical and Radiological Parameters of Secondary Progressive Multiple Sclerosis: A Real-World Prospective Study
    Stavrogianni, Konstantina
    Kitsos, Dimitrios K.
    Giannopapas, Vasileios
    Stefanou, Maria-Ioanna
    Christouli, Niki
    Smyrni, Vassiliki
    Chasiotis, Athanasios K.
    Akrivaki, Alexandra
    Dimitriadou, Evangelia
    Chondrogianni, Maria
    Tsivgoulis, Georgios
    Giannopoulos, Sotirios
    JOURNAL OF CLINICAL NEUROLOGY, 2024, 20 (06): : 591 - 598
  • [8] Real-world data on siponimod-related lymphopenia among people with secondary progressive multiple sclerosis
    Gilmartin, Christopher G. S.
    Hoyle, Natasha
    Garjani, Afagh
    Dixon, Terri
    Jos, Helena
    Paling, David
    Brownlee, Wallace
    Tench, Christopher
    Evangelou, Nikos
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (4-5) : 600 - 604
  • [9] Real-World Outcomes With Cladribine Tablets in People With Relapsing Multiple Sclerosis
    Okuda, Darin
    Livingston, Terrie
    Moog, Tatum
    Smith, Alexander
    Lebson, Lori
    Piette, Elizabeth
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 1100 - 1100
  • [10] A real-world cohort analysis of alemtuzumab outcomes in relapsing multiple sclerosis
    Herman, Jorge Acevedo
    Khalighinejad, Farnaz
    York, Katherine
    Radu, Irina
    Morales, Idanis Berrios
    Ionete, Carolina
    Hemond, Christopher C.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 47